Press Releases May 05, 2020


Lawrenceville, NJ, and Lenexa, KS – May 4, 2020 Kansas-based pharmaceutical technology company develops customized formulations and intellectual property Deal includes platforms that can be dosed in oral, injectable and otic (ear) formulations Acquisition expands Adare’s technology platforms and product development capabilities Adare Pharmaceuticals, Inc., a clinical-stage pharmaceutical company and leading global provider of advanced […]

News Apr 07, 2020

Universities Turn on the Faucet of Entrepreneurship so Corporations Can Tap In

This story is part of a series that explores how Kansas City corporations are supporting entrepreneurship and why corporate engagement is important. For more, explore the new We Create Corporate Engagement report. By Kelly Scanlon March 17, 2020 About a half dozen people pore over computer monitors arranged in two workstation clusters. Others are busy at […]

News Mar 31, 2020

Biotech firm seeks to advance novel exosome isolation-based therapy for COVID-19 into clinical trials

By: Startland Staff–   March 27, 2020 COVID-19, Fusion Medical Animation Editor’s note: The following is part of Startland News’ ongoing coverage of the impact of Coronavirus (COVID-19) on Kansas City’s entrepreneur community, as well as how innovation is helping to drive a new normal in the ecosystem. Click here to follow related stories as they develop. As the global […]

News Mar 31, 2020

Lawrence-based Clara Biotech seeking clinical trial for possible COVID-19 therapy

photo by: Sara Shepherd/Journal-World File Photo By: Conner Mitchell A Lawrence biotechnology company is in the process of solidifying clinical trials for a therapy that could drastically reduce the more complicated symptoms of COVID-19. Clara Biotech, based on the University of Kansas’ west campus, says it has developed a way to directly target infected lung tissue […]

Press Releases Mar 26, 2020

PrairieFood adds Senior Syngenta Executive to Advisory Board

Lawrence, Kansas, March 25th, 2020 — PrairieFood, developer of an innovative approach to converting waste biomass, some of which is hazardous, into safe valuable high carbon products for agriculture and other sectors, announces Vern Hawkins, president of Syngenta Crop Protection, LLC, has joined its Board of Advisors. Hawkins has provided innovation and commercialization leadership to […]

News Mar 03, 2020

Ligand CEO on how company’s helping find a cure for the coronavirus

John Higgins, Ligand Pharmaceuticals CEO, joins ‘Power Lunch’ to discuss how the company’s drug discovery technology is helping with the race to find a cure for the coronavirus. CNBC recently interviewed John Higgins, CEO of Ligand, and asked about the company’s connection to Remdesivir, which is being used in the country’s first clinical trials for […]

News Feb 20, 2020

KU research, startup company at forefront of exosome isolation in cancer research

By Lindsey Slater  – Director of Communications You may have never heard of an exosome, but research involving these vesicles has boomed. Exosomes have a variety of clinical applications, like targeted drug delivery or liquid biopsies. A Lawrence company is on the forefront of technology that tackles the challenging process of isolating exosomes for research. […]

News Feb 20, 2020

Kelly, Girod discuss efforts to bolster Kansas workforce amid budget concerns

University of Kansas Chancellor Douglas Girod, second from left, Secretary of Commerce David Toland, middle, and Gov. Laura Kelly, right, discuss efforts to bolster and retain the state’s workforce during a roundtable discussion on Wednesday, Feb. 12, 2020, in Lawrence. Photo by: Conner Mitchell   University of Kansas Chancellor Douglas Girod and Gov. Laura Kelly […]

News Feb 20, 2020

On The Cutting Edge

Companies right here in Lawrence create innovative technology for the health-care industry to save lives all across the globe. | 2019 Q4 | story by Tara Trenary | photos by Steven Hertzog Technology plays a crucial role in many industries, but health care is one of the most important. Technological advances in medicine in areas […]

Press Releases Feb 18, 2020

ArTara Therapeutics Completes Merger Transaction with Proteon Therapeutics

 January 10, 2020 Shares of ArTara to commence trading on Nasdaq under new ticker symbol “TARA” effective January 10, 2020 Company completes previously announced equity financing of $42.5 million concurrently with the closing of the merger Combined company will focus on developing treatments for Lymphatic Malformations and intestinal failure associated liver disease NEW YORK, Jan. 09, 2020 (GLOBE NEWSWIRE) […]